Skip to content
Home  /  RANZCR Part 1  /  Study notes  /  Dose Limits, Shielding and Occupational Monitoring

Dose Limits, Shielding and Occupational Monitoring

● RANZCR Part 1 LO 2.3.21LO 2.3.22LO 2.3.23LO 2.3.24LO 2.3.25 2,905 words
Free preview. This study note covers 5 learning objectives (2.3.21, 2.3.22, 2.3.23, 2.3.24, 2.3.25) from the RANZCR Part 1 curriculum. Inside PRIMEX you get AI-graded SAQ practice on this topic, MCQs across the full syllabus, and a curriculum tracker that ticks off every learning objective.

Overview

The core methods of dose reduction are:

  1. Time: minimising duration of exposure
  2. Distance: maximising separation from the radiation source
  3. Shielding: interposing attenuating material between source and receptor
  4. Access control: restricting who can enter high-dose areas

These principles apply in both diagnostic radiology (X-ray, fluoroscopy, CT) and nuclear medicine (SPECT, PET, PET/CT), though the relative importance and practical implementation differ significantly between modalities.


Controlled vs Uncontrolled Areas

Parameter Controlled Area Uncontrolled Area
Definition Access controlled; occupational exposure supervised by radiation protection supervisor Most other hospital/clinic areas (e.g. offices adjacent to X-ray rooms)
Typical occupants Radiographers, radiologists, nurses, technologists General public, office staff, visitors
Individual monitoring Required (personal dosimeters) Not routinely monitored
Shielding design goal $P$ (annual) $5~\text{mGy/year}$ $1~\text{mGy/year}$
Shielding design goal $P$ (weekly) $0.1~\text{mGy/week}$ $0.02~\text{mGy/week}$
Basis Voluntary occupational exposure Involuntary, potentially unaware exposure

Method 1: Time Reduction

Principle

$$E \propto \dot{D} \times t$$

where $\dot{D}$ is the dose rate and $t$ is duration of exposure.

Diagnostic Radiology

Nuclear Medicine


Method 2: Distance

Inverse Square Law

$$I \propto \frac{1}{d^2} \qquad \frac{I_1}{I_2} = \frac{d_2^2}{d_1^2}$$

Scatter in Diagnostic X-ray

At $1~\text{m}$ from a patient at 90° to the primary beam, scatter intensity is approximately 0.1-0.15% of the incident beam intensity for a standard fluoroscopy field area of $400~\text{cm}^2$.

Diagnostic Radiology

Nuclear Medicine


Method 3: Protective Clothing (Personal Protective Equipment)

PPE Item Material Application Notes
Lead apron Lead / lead-equivalent composite Fluoroscopy, interventional procedures Effective at diagnostic energies; impractical for $511~\text{keV}$
Thyroid collar Lead-equivalent Fluoroscopy Protects thyroid from scatter
Leaded glasses Lead-equivalent glass/acrylic Interventional fluoroscopy Reduces lens dose; cataract risk mitigation
Protective gloves Lead-impregnated rubber Fluoroscopy, nuclear medicine Reduces hand dose from scatter
Syringe shields Lead or tungsten Nuclear medicine dose preparation Reduces hand dose during injection and dispensing

Limitations

Dosimetry Placement


Method 4: Shielding Barriers

Fixed Structural Shielding

Primary vs Secondary Barriers

Barrier Type Definition Radiation Attenuated Rooms
Primary barrier Intercepts the unattenuated primary beam Direct (primary) X-ray beam Radiographic rooms, dedicated chest rooms, R&F rooms
Secondary barrier All other barriers Scattered radiation from patient + tube leakage All rooms; sole barrier type in fluoroscopy, mammography, and CT

Use Factor $U$

Shielding Materials

Material Application Notes
Lead Diagnostic X-ray, SPECT nuclides High $Z$ enhances photoelectric absorption; thin layers effective at $\leq 140~\text{keV}$
Lead-lined drywall Walls in diagnostic rooms Practical construction material; common thicknesses $0.79~\text{mm}$ ($2~\text{lb/ft}^2$) and $1.58~\text{mm}$ ($4~\text{lb/ft}^2$)
Concrete PET facilities, bulk shielding Structural support; required thickness is large for $511~\text{keV}$
Lead acrylic (transparent) Viewing windows, mobile ceiling-mounted shields in fluoroscopy suites Allows unobstructed operator viewing
Tungsten Syringe shields, compact source containers Very high density; expensive

Shielding Design Calculation Framework

The key design formula uses the dimensionless ratio:

$$\frac{NT}{Pd^2}$$

where:

Required lead (or concrete) thickness is read from NCRP Report No. 147 charts for the appropriate room type and barrier.

Point of closest approach (reference points):

Conservative assumptions in design include: (1) no attenuation of the primary beam by the patient (patient typically attenuates by factor 10-100); (2) perpendicular beam incidence on barriers (maximum transmission); (3) ignoring other attenuating materials in the beam path.

Worked Example (Primary Barrier)

Chest bucky wall in a general radiographic room:

$$\frac{NT}{Pd^2} = \frac{120 \times 0.2}{0.02 \times (2.4)^2} = \frac{24}{0.1152} \approx 208$$

From NCRP 147 charts: approximately $1.3~\text{mm}$ lead required → specified as $4~\text{lb/ft}^2$ ($1.58~\text{mm}$) installed from finished floor to $2.1~\text{m}$ height, with $\geq 0.5~\text{m}$ lateral margins around the image receptor.

For the adjacent secondary barrier (same chest bucky wall): closest distance $= 1.5~\text{m}$:

$$\frac{NT}{Pd^2} = \frac{120 \times 0.2}{0.02 \times (1.5)^2} = 533$$

This yields approximately $0.6~\text{mm}$ lead → specified as $2~\text{lb/ft}^2$, installed continuously and seamlessly with the primary barrier.

CT Shielding

Nuclear Medicine and PET/CT Shielding

Source Photon Energy Shielding Material Notes
Tc-99m (SPECT) $140~\text{keV}$ Lead Thin lead sufficient; relatively straightforward
F-18 (PET) $511~\text{keV}$ annihilation photons Lead, high-density concrete Much greater thickness required; structural weight a major consideration
Other SPECT nuclides Typically $<365~\text{keV}$ (some higher-energy $\gamma$ at low abundance) Lead Varies by nuclide
SPECT/CT CT component + SPECT nuclide Lead/concrete Shielding calculation required for CT component

Weight management strategies for PET/CT facilities:

Radiopharmacy: Requires shielded workbenches, storage containers, and potentially structural shielding; located near injection and imaging rooms to minimise transport distances.

Portable and Mobile Shielding


Method 5: Restricting Access to Radiation Areas

Controlled Area Access Controls

Nuclear Medicine-Specific Access Controls


Comparison: Diagnostic Radiology vs Nuclear Medicine

Parameter Diagnostic Radiology Nuclear Medicine
Source type X-ray machine (controllable, intermittent) Radioactive patient/vial (continuous, uncontrollable once administered)
Photon energy range $\leq 140~\text{keV}$ (diagnostic X-ray); $511~\text{keV}$ (PET CT component) $140~\text{keV}$ (Tc-99m) to $511~\text{keV}$ (F-18); others vary
Primary protection method Structural shielding + distance Distance (primary); structural shielding where feasible
Protective clothing utility High importance during fluoroscopy/interventional Limited for high-energy photons; syringe shields and gloves useful
Time reduction strategy Minimise fluoroscopy time; efficient technique Minimise time near patients; efficient injection and dose preparation
Access restriction Interlocks, beam-on warning lights, controlled area design Hot zones, restricted corridors, post-injection patient management
Mobile sources Mobile X-ray and fluoroscopy units Ambulant patients containing radiopharmaceuticals
Shielding materials Lead, lead-lined drywall, lead acrylic Lead (SPECT), high-density concrete/thick lead (PET)
Shielding design standard NCRP Report No. 147 AAPM Report No. 108 (PET/CT); NCRP 147 for CT component

Post-Installation Quality Assurance

After shielding installation, a radiation protection survey by a qualified expert is mandatory:


Summary: Key Principles

  1. Time, distance, and shielding are the universal triad of radiation protection in all environments
  2. In diagnostic radiology, structural shielding is the dominant tool; protective clothing and mobile shields supplement during fluoroscopy and interventional procedures
  3. In nuclear medicine, distance is the primary protective tool due to higher and less readily attenuatable photon energies; facility shielding is essential but weight-intensive for PET
  4. Controlled areas: $P = 0.1~\text{mGy/week}$; uncontrolled areas: $P = 0.02~\text{mGy/week}$ (air kerma design goals per NCRP 147)
  5. Occupancy factor $T$ and use factor $U$ tailor shielding to actual usage patterns, avoiding over-engineering
  6. Facility siting decisions (floor level, wall orientation, adjacent room types) can substantially reduce shielding mass, particularly critical for PET/CT
  7. Access restriction through interlocks, physical design, and administrative controls protects members of the public who cannot be individually monitored
  8. ALARA remains the overarching principle: dose reduction beyond regulatory limits is always sought where reasonably practicable
PRIMEX

Practice this topic in the app

Attempt a graded SAQ on this exact LO or work through MCQs that map to 2.3.21, 2.3.22, 2.3.23, 2.3.24, 2.3.25. Your free trial covers all 26 exams.

Start 7-day free trial

7-day free trial · Cancel anytime

Quick recall flashcards

A small sample of the deck for this topic. Tap a question to reveal the answer. The full deck and spaced-repetition scheduler live inside PRIMEX.

What is the primary purpose of establishing radiation dose limits for workers and the public?
  • To keep the probability of stochastic effects (cancer, heritable effects) acceptably low
  • To prevent deterministic effects (cataracts, skin damage, bone marrow suppression) entirely
  • Limits are upper bounds, not targets; ALARA applies below them
What is the ICRP recommended annual effective dose limit for occupationally exposed workers?
  • 20 mSv per year, averaged over a defined 5-year period
  • With the additional constraint that no single year exceeds 50 mSv
What is the ICRP recommended annual effective dose limit for members of the public?
  • 1 mSv per year
  • This is an effective dose limit, exclusive of natural background and medical exposures
What dose limit applies to the fetus of a declared pregnant radiation worker under ICRP recommendations?
  • Equivalent dose to the embryo/fetus should not exceed 1 mSv over the entire pregnancy once declared
  • Applies from the time pregnancy is declared to the employer
Start free trial→